OvaReady: An Automated Way to Prepare Eggs for IVF
Official title: OvaReady: An automated microfluidic oocyte retrieval and denudation device
Funded at Autoivf, INC. · NIH-11067713 · Data updated 2026-11-12
This project is developing a new automated system called OvaReady to make the process of preparing eggs for In-Vitro Fertilization (IVF) more efficient and accessible for people trying to conceive.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Autoivf, INC. NIH-funded |
| Lab location | 1 site (Natick, UNITED STATES) |
| Project start | September 21, 2021 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $997,028 |
| NIH project number | 2R44HD105529-04 |
| Project ID | NIH-11067713 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is relevant for individuals or couples who are undergoing or considering In-Vitro Fertilization (IVF) treatments, especially those who cannot achieve pregnancy naturally.
✕Less likely to help
Patients not seeking or undergoing fertility treatments like IVF would not directly benefit from this specific technology.
What this research studies
OvaReady is a new automated technology designed to improve the In-Vitro Fertilization (IVF) process. It works by automatically isolating and preparing egg cells from follicular fluid, which is a crucial step before procedures like ICSI or freezing eggs. This automated system aims to make IVF treatments safer and more consistent by reducing manual handling and exposure to environmental changes. The goal is to increase the number of healthy eggs recovered and maintain their quality, which can lead to better chances of success for patients. This innovation also seeks to broaden access to fertility treatments by allowing egg collection and preparation at satellite clinics.
Why it matters
Potential benefit: If successful, this technology could make IVF treatments more efficient, safer, and more widely available, potentially improving pregnancy rates for those struggling with infertility.
How similar studies have gone: Preliminary studies have shown that OvaReady can recover more eggs and preserve their quality better than traditional manual methods, suggesting a promising advancement in IVF technology.
Where this research is happening
-
Autoivf, INC.
Natick, United States Active
Researchers
- Principal investigator: Ozkumur, Ismail Emre — Autoivf, INC.
- Study coordinator: Ozkumur, Ismail Emre
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.